Figure 1.
Flow chart of patients enrolled and included in the analysis of the impact of antiviral therapy on mortality.
*Missing data for pneumonia (n = 20); ¶missing data for corticosteroid (n = 9); ※missing data for timing or whether oseltamivir was prescribed (n = 109).
Figure 2.
Cox regression for survival probability of pneumonia patients with antiviral therapy (Oseltamivir).
Figure 3.
Estimates of hazard ratio for in-hospital mortality among patients with antiviral therapy, as compared with patients with no antiviral therapy.
For patients aged<14 yrs or > = 14 yrs, adjusted for sex, and baseline APACHE II score; For age subgroup analysis among patients aged> = 14 yrs, adjusted for sex, and baseline APACHE II; for sex subgroup analysis among patients aged> = 14 yrs, adjusted for age, and baseline APACHE II; for baseline PaO2/FiO2, subgroup analysis among patients aged> = 14 yrs, adjusted for age, and sex.